We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+5.45%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$274M
AUM Growth
+$28.9M
Cap. Flow
+$18.1M
Cap. Flow %
6.61%
Top 10 Hldgs %
33.26%
Holding
58
New
20
Increased
13
Reduced
10
Closed
11

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$9.27M
2
ISRG icon
Intuitive Surgical
ISRG
+$7.55M
3
COR icon
Cencora
COR
+$6.22M
4
WAT icon
Waters Corp
WAT
+$5.87M
5
FMS icon
Fresenius Medical Care
FMS
+$5.48M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.66M
2
ELV icon
Elevance Health
ELV
+$6.42M
3
LLY icon
Eli Lilly
LLY
+$5.91M
4
CAH icon
Cardinal Health
CAH
+$5.36M
5
GH icon
Guardant Health
GH
+$5.29M

Sector Composition

Rank Sector Weight
1 Healthcare 98.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCK icon
26
McKesson
MCK
$102B
$5.85M 2.13%
30,000
-25,000
-45% -$4.56M
AVTR icon
27
Avantor
AVTR
$9.38B
$5.79M 2.11%
200,000
-50,000
-20% -$1.44M
JNJ icon
28
Johnson & Johnson
JNJ
$628B
$5.75M 2.1%
35,000
-30,000
-46% -$4.85M
FMS icon
29
Fresenius Medical Care
FMS
$12.6B
$5.35M 1.95%
+145,000
New +$5.48M
BRKR icon
30
Bruker
BRKR
$9B
$5.14M 1.88%
+80,000
New +$4.81M
BMRN icon
31
BioMarin Pharmaceuticals
BMRN
$13.6B
$4.53M 1.65%
60,000
-20,000
-25% -$1.63M
PPD
32
DELISTED
PPD, Inc. Common Stock
PPD
$4.16M 1.52%
+110,000
New +$3.95M
GMED icon
33
Globus Medical
GMED
$11.5B
$4.01M 1.46%
+65,000
New +$4.12M
HRC
34
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.87M 1.41%
+35,000
New +$3.65M
BIO icon
35
Bio-Rad Laboratories Class A
BIO
$9.65B
$3.71M 1.35%
6,500
-1,500
-19% -$888K
BIIB icon
36
Biogen
BIIB
$30.9B
$3.5M 1.28%
+12,500
New +$3.37M
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$133B
$3.22M 1.18%
+15,000
New +$3.29M
HAE icon
38
Haemonetics
HAE
$4.14B
$2.77M 1.01%
+25,000
New +$3.09M
INNV icon
39
InnovAge Holding
INNV
$1.42B
$2.19M 0.8%
+85,000
New +$2.09M
BNTX icon
40
BioNTech
BNTX
$23.3B
$2.18M 0.8%
+20,000
New +$2.12M
QURE icon
41
uniQure
QURE
$3.13B
$2.08M 0.76%
+61,768
New +$2.21M
MRNA icon
42
Moderna
MRNA
$25.4B
$1.96M 0.72%
+15,000
New +$2.17M
ARGX icon
43
argenx
ARGX
$54.7B
$1.79M 0.65%
+6,500
New +$2.05M
MRTX
44
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.71M 0.62%
+10,000
New +$1.98M
GH icon
45
Guardant Health
GH
$22.2B
$1.53M 0.56%
10,000
-35,000
-78% -$5.29M
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.93B
$1.49M 0.54%
+20,000
New +$1.85M
TPTX
47
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.23M 0.45%
+13,000
New +$1.55M
ADPT icon
48
Adaptive Biotechnologies
ADPT
$4.01B
– –
-20,000
Closed -$1.18M
CAH icon
49
Cardinal Health
CAH
$54.5B
– –
-100,000
Closed -$5.36M
ELAN icon
50
Elanco Animal Health
ELAN
$11.1B
– –
-150,000
Closed -$4.6M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q1 2021 Portfolio in Review

As of Q1 2021, Sivik Global Healthcare held 58 positions worth $274M, up 12% from $245M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Sivik Global Healthcare deployed $18.1M of net new capital in Q1 2021, opening 20 new positions and adding to 13 existing holdings. Its largest new stake was Agilent Technologies: 75,000 shares worth $9.54M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

On the sell side, the largest reduction was Guardant Health, an estimated $5.29M trimmed.

  • Sivik Global Healthcare's largest Q1 2021 buy was Agilent Technologies: 75,000 shares worth $9.54M.
  • Sivik Global Healthcare added most to Encompass Health in Q1 2021, an estimated $3.69M increase.
  • Sivik Global Healthcare's biggest Q1 2021 reduction was Guardant Health, cutting an estimated $5.29M.
  • Sivik Global Healthcare fully exited Regeneron Pharmaceuticals in Q1 2021, selling an estimated $9.66M.
  • Sivik Global Healthcare's ten largest holdings make up 33% of its $274M portfolio in Q1 2021.
  • Sivik Global Healthcare opened 20 new positions and closed 11 in Q1 2021.
  • Sivik Global Healthcare's portfolio value rose 12% quarter-over-quarter to $274M.

Based on Sivik Global Healthcare's 13F filing for Q1 2021, filed 12 May 2021.